|
|
|
|
||
REPORTED $14.92 Optimer Pharma misses by $0.19, misses on revs (OPTR) 14.92 +0.13 : Reports Q1 (Mar) loss of $0.65 per share, $0.19 worse than the Capital IQ Consensus Estimate of ($0.46); revenues rose 35.1% year/year to $19.43 mln vs the $21.3 mln consensus. |
return to message board, top of board |